These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4683346)

  • 1. The effect of methyl CCNU (NSC-95441) on the cellular kinetics of normal and leukemic murine tissues in vivo.
    Young RC
    Cell Tissue Kinet; 1973 Jan; 6(1):35-43. PubMed ID: 4683346
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in 3H-thymidine incorporation into DNA induced by methyl CCNU (1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea) in normal and tumorous tissues in vivo.
    Young RC; Goldberg D; Grotzinger KR
    Cell Tissue Kinet; 1976 Jul; 9(4):325-32. PubMed ID: 1277265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
    Rosenoff SH; Bostick F; Young RC
    Biochem Pharmacol; 1974 Nov; 23(22):3097-106. PubMed ID: 4441409
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA; DeVita VT; Adamson RH; Oliverio VT
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
    Brereton HD; Bryant TL; Young RC
    Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chemotherapy on the growth of leukemia L1210. II. Persistence of a nitrosourea-induced change in the growth characteristics of transplant generations.
    DeVita VT; Bray DA; Bostick F; Bagley CM
    Cell Tissue Kinet; 1972 Nov; 5(6):459-66. PubMed ID: 4654583
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of radioprotective compounds on the incorporation of tritiated thymidine into mammalian cells.
    Simons HA; Davis EM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1966; 10(4):343-52. PubMed ID: 5297014
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of N-nitroso-N'-methylurea on the cellular kinetics in tumors].
    Ostrovskaia LA; Frankfurt OS
    Vopr Onkol; 1977; 23(2):88-93. PubMed ID: 857417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210.
    DeVita VT; Denham C; Perry S
    Cancer Res; 1969 May; 29(5):1067-71. PubMed ID: 5781099
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical events in the cell cycle.
    Baserga R
    Natl Cancer Inst Monogr; 1969 May; 30():1-14. PubMed ID: 5361647
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of mechanism of action studies of the nitrosoureas.
    Bono VH
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract]   [Full Text] [Related]  

  • 15. Mouse peritoneal macrophages: tritiated thymidine labeling and cell kinetics.
    Shands JW; Axelrod BJ
    J Reticuloendothel Soc; 1977 Jan; 21(1):69-76. PubMed ID: 845860
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of CCNU on hematopoiesis in rats.
    Haas RJ; Rohruber W; Netzel B; Lau E
    Cancer Treat Rep; 1979 Mar; 63(3):377-83. PubMed ID: 427820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
    Killmann SA
    Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.
    Panasci LC; Fox PA; Schein PS
    Cancer Res; 1977 Sep; 37(9):3321-8. PubMed ID: 141978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.